Karnauskas Favors Amgen Purchase of Onyx (Audio)

Robyn Karnauskas, a New York-based analyst at Deutsche Bank AG, says Amgen's purchase of Onyx Pharmaceuticals Inc. (ONXX) gives Amgen "top line growth" in the cancer-drug market. Karnauskas talks with Bloomberg's Tom Keene and Joe Brusuelas on Bloomberg Radio's "Bloomberg Surveillance."

(Source: Bloomberg)

Running time 05:38